Michael C. Angelini

Cardiovascular Considerations for Stimulant Class Medications.

T. Wilens, P. Hammerness, A. Berger, 2022, Child and adolescent psychiatric clinics of North America.

The anticholinergic risk scale and anticholinergic adverse effects in older persons.

R. McGlinchey, J. Rudolph, Michael C. Angelini, 2008, Archives of internal medicine.

A systematic review of community-based interventions to improve oral chronic disease medication regimen adherence among individuals with substance use disorder.

K. Clements, B. Greenwood, Michael C. Angelini, 2018, Drug and alcohol dependence.

Implementation of an Opioid Management Initiative by a State Medicaid Program

K. Lenz, P. Jeffrey, Michael C. Angelini, 2014, Journal of managed care & specialty pharmacy.

Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program Between 2002 and 2017.

K. Clements, K. Lenz, P. Jeffrey, 2019, The journal of pain : official journal of the American Pain Society.

The anticholinergic risk scale and anticholinergic adverse effects in older persons.

R. McGlinchey, J. Rudolph, Michael C. Angelini, 2008, Archives of internal medicine.

Increase in plasma levels of clozapine after addition of isoniazid.

S. Dizio, Michael C. Angelini, Jacqueline MacCormack-Gagnon, 2009, Journal of clinical psychopharmacology.